Marie‐Jeanne P. Gerritsen

Author

Radboud University Nijmegen ORCID

Also Known As

M Gerritsen, Marie-Jeanne Gerritsen, Marie-Jeanne P Gerritsen, Marie-Jeanne P. Gerritsen, Marie‐Jeanne P. Gerritsen

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center University Hospital and Clinics Leiden University Medical Center University Medical Center

About

Marie‐Jeanne P. Gerritsen is an author at Radboud University Nijmegen specializing in medicine, dermatology, and dermatopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	474
2	Health Sciences	1	1	13
3	Nursing	1	1	13
4	Biochemistry	1	1	58
5	Geriatrics	1	1	13

Marie‐Jeanne P. Gerritsen

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. I. Jolanda M. de Vries, W. Joost Lesterhuis, Nicole M. Scharenborg, PubMed	2003	329
Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome Maarten H. Vermeer, Remco van Doorn, Remco Dijkman, Cancer Research	2008	194
Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology Rolf‐Markus Szeimies, Marie‐Jeanne P. Gerritsen, G. Gupta, Journal of the American Academy of Dermatology OphthalmologyImiquimod 5Phase IiiSurgeryDermatology	2004	192
Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome I. Jolanda M. de Vries, Monique R. Bernsen, W. Joost Lesterhuis, Journal of Clinical Oncology	2005	184
Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma Léon C.L.T. van Kempen, Jos Rijntjes, Ine Mamor‐Cornelissen, International Journal of Cancer	2007	81
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used W. Joost Lesterhuis, Gerty Schreibelt, Nicole M. Scharenborg, Cancer Immunology Immunotherapy VaccinationMelanomaImmunologyTherapeutic VaccineLong-term Clinical Responses	2010	79
In vivo Diagnosis of Basal Cell Carcinoma Subtype by Reflectance Confocal Microscopy Malou Peppelman, Esther A.W. Wolberink, Willeke A.M. Blokx, Dermatology	2013	61
<i>In situ</i> Expression of Tumor Antigens by Messenger RNA–Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients Danita H. Schuurhuis, Pauline Verdijk, Gerty Schreibelt, Cancer Research	2009	61
Correlation Between Macroscopic Fluorescence and Protoporphyrin IX Content in Psoriasis and Actinic Keratosis Following Application of Aminolevulinic Acid T. Smits, Cesar A. Robles, P.E.J. van Erp, Journal of Investigative Dermatology Protoporphyrin Ix ContentBiochemistryCutaneous BiologyClinical DermatologyCytoskeleton	2005	58
Fluorescence diagnosis in keratinocytic intraepidermal neoplasias T. Smits, Marloes M. Kleinpenning, Willeke A.M. Blokx, Journal of the American Academy of Dermatology MedicineHistopathologyDermatologyDermatopathologyFluorescence Diagnosis	2007	42

Page 1